Inactive Instrument

Iomai Corporation Share Price

Equities

US46202P1030

Pharmaceuticals

End-of-day quote Nasdaq
- - Intraday chart for Iomai Corporation
Managers TitleAgeSince
Director/Board Member 54 -
Director/Board Member 58 30/11/15
Corporate Officer/Principal - 31/07/08
Members of the board TitleAgeSince
Director/Board Member 81 31/12/05
Director/Board Member 61 31/10/17
Director/Board Member 85 04/07/06
More insiders
Intercell USA, Inc. provides products for the delivery of vaccines to the skin through a proprietary technology known as transcutaneous immunization, or TCI. The Company is evaluating skin immunization techniques in several human clinical trials, including those to prevent influenza in the healthy adult and elderly populations, and also to prevent travelers' diarrhea and anthrax infection.
More about the company